Delineation of pathogenic mechanisms of NOS1AP and TRIM8 mutations in monogenic SRNS/FSGS.
描述单基因 SRNS/FSGS 中 NOS1AP 和 TRIM8 突变的致病机制。
基本信息
- 批准号:10214843
- 负责人:
- 金额:$ 16.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:ActinsAdaptor Signaling ProteinAdvisory CommitteesAlbuminuriaAntibodiesBiologicalBloodBostonCDC42 geneCell physiologyCellsChildChildhoodChronicChronic Kidney FailureCo-ImmunoprecipitationsCoupledCreatinineCritical PathwaysDataDefectDevelopment PlansDiffuseDiseaseDisease modelEdemaElectron MicroscopyEnd stage renal failureEnsureEnvironmentEpilepsyExhibitsFamilyFocal Segmental GlomerulosclerosisFoot ProcessFunctional disorderFundingGenesGeneticGrantGrowthGuanine Nucleotide Exchange FactorsHandHumanHypoalbuminemiaImmunofluorescence ImmunologicImmunoprecipitationImpairmentKidneyKidney FailureKidney GlomerulusKnock-inLabelLaboratoriesLifeMediatingMedicineMentorsMethodologyMicroscopyModelingMusMutateMutationNephrologyNephrotic SyndromeNitric Oxide Synthase Type INuclearNucleoplasmPathogenesisPathogenicityPathway interactionsPatientsPediatric HospitalsProgram DevelopmentProteinsProteinuriaProteomicsPublicationsResearchResearch ProposalsResearch SupportResistanceRoleScienceSerumSerum AlbuminServicesSteroid therapySteroid-resistant idiopathic nephrotic syndromeStructureTrainingUbiquitinUrineVocational GuidanceWestern Blottingbasecareercareer developmentglomerulosclerosisinnovationkidney biopsylight microscopyliquid chromatography mass spectrometrymedical schoolsmeetingsmigrationmouse modelmutantnoveloverexpressionpodocyteresearch and developmentsuccesssymposiumubiquitin-protein ligase
项目摘要
PROJECT SUMMARY
Title:Delineation of pathogenic mechanisms of NOS1AP and TRIM8 mutations in monogenic SRNS/FSGS
Steroid resistant nephrotic syndrome (SRNS) is a leading cause of childhood chronic kidney disease1, marked
by proteinuria and edema. Renal biopsy typically reveals focal segmental glomerulosclerosis (FSGS). 59% of
children with SRNS are unresponsive to standard therapy1,2. A majority of them progress to end-stage renal
disease with loss of the kidney glomerular filtering cells, podocytes1,2. Mendelian genetic causes of SRNS/FSGS
have been detected in ~11-30% of pediatric cases3–6. SRNS/FSGS disease genes encode critical pathway
components in podocyte biology2,7–10. Human mutations impair these SRNS/FSGS pathways, causing
podocytopathies2,7–10.
The proposed research will explore the pathogenic mechanisms underlying two novel monogenic causes of
SRNS/FSGS in human NOS1AP and TRIM8 mutations, which were discovered by the applicant. The applicant’s
preliminary data generated the hypothesis that human NOS1AP and TRIM8 mutations cause SRNS/FSGS
through dysregulation of the CDC42 pathway and TRIM8 E3 ligase functions, respectively. The applicant,
thus, proposes the following specific aims (SAs) using innovative cell biological, proteomics, and mouse
models approaches: (SA1) Define the mechanism of CDC42 dysregulation caused by NOS1AP SRNS
mutations; (SA2) Dissect the pathogenesis of TRIM8 SRNS/FSGS mutations in podocytes; (SA3) Delineate the
pathogenesis of NOS1AP and TRIM8 mutations in SRNS in mice.
The applicant has created a comprehensive career development plan supported by his mentor to (1)
ensure his progress and success in carrying out this research proposal and (2) to facilitate his transition
to an independent research career focused on disease modeling of nephrotic syndrome. This plan begins
with regular meetings with his mentor and advisory committee—national and global academic leaders in
medicine and science—to provide research and career guidance. The plan additionally includes (i) research and
career development seminars, (ii) proteomics and microscopy methodology courses and (iii) activities for career
growth including conference presentations and publications, mentoring of junior trainees, and application for
independent research funding. The applicant and mentor have, also, agreed upon a transition plan to distinguish
himself from the mentor’s laboratory. His training will be carried out in an unparalleled academic environment at
Boston Children’s Hospital and Harvard Medical School, which provides dedicated career development
programs and all necessary research support and supplies through his mentor and institutional core services.
Collectively, this research and career development proposal is a product of the applicant’s ambition and
capacity to transition to an independent research career in nephrology.
项目摘要
标题:单基因SRNS/FSG中NOS1AP和TRIM8突变的致病机理的描述
抗类固醇肾病综合征(SRN)是儿童慢性肾脏病的主要原因1,标记为
由蛋白尿和水肿。肾脏活检通常揭示局灶性节段性肾小球硬化症(FSGS)。 59%
SRN的儿童对标准疗法没有反应1,2。他们中的大多数发展到终端肾脏
肾脏肾小球滤波细胞丧失的疾病,足细胞1,2。 Mendelian遗传原因SRNS/FSGS
在约11-30%的小儿病例中检测到3-6。 SRNS/FSGS疾病基因编码关键途径
足细胞生物学中的成分2,7-10。人类突变会损害这些SRN/FSGS途径,导致
足细胞病2,7-10。
拟议的研究将探索两个新的单基因原因的致病机制
申请人发现的人NOS1AP和TRIM8突变中的SRN/FSG。申请人的
初步数据产生了以下假设:人NOS1AP和TRIM8突变引起SRNS/FSGS
通过CDC42途径和TRIM8 E3连接酶功能的失调。申请人,
因此,建议使用创新细胞生物学,蛋白质组学和小鼠的以下特定目标(SAS)
模型方法:( SA1)定义由NOS1AP SRN引起的Cdc42失调的机理
突变; (SA2)剖析足细胞中TRIM8 SRNS/FSGS突变的发病机理; (SA3)描述
小鼠SRN中NOS1AP和TRIM8突变的发病机理。
申请人制定了一项全面的职业发展计划,由他的心理支持(1)
确保他在执行这项研究建议方面的进步和成功,(2)促进他的过渡
独立研究职业专注于肾病综合征的疾病建模。这个计划开始了
与他的心理和咨询委员会定期会议 - 本地和全球学术领袖
医学和科学 - 提供研究和职业指导。该计划还包括(i)研究和
职业发展半货人,(ii)蛋白质组学和显微镜方法学课程以及(iii)职业活动
增长包括会议演讲和出版物,初级学员的心理以及申请
独立研究资金。申请人和精神上也同意了一个过渡计划,以区分
他自己来自精神实验室。他的培训将在无与伦比的学术环境中进行
波士顿儿童医院和哈佛医学院,提供专门的职业发展
计划以及所有必要的研究通过其心理和机构核心服务提供支持和供应。
总的来说,这项研究和职业发展建议是申请人的野心和
过渡到肾脏病独立研究职业的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amar J Majmundar其他文献
Amar J Majmundar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amar J Majmundar', 18)}}的其他基金
Delineation of pathogenic mechanisms of NOS1AP and TRIM8 mutations in monogenic SRNS/FSGS.
描述单基因 SRNS/FSGS 中 NOS1AP 和 TRIM8 突变的致病机制。
- 批准号:
10379338 - 财政年份:2021
- 资助金额:
$ 16.94万 - 项目类别:
Delineation of pathogenic mechanisms of NOS1AP and TRIM8 mutations in monogenic SRNS/FSGS.
描述单基因 SRNS/FSGS 中 NOS1AP 和 TRIM8 突变的致病机制。
- 批准号:
10596564 - 财政年份:2021
- 资助金额:
$ 16.94万 - 项目类别:
相似海外基金
Molecular Mechanisms Underlying Endothelial Weibel-Palade Body Biogenesis and Exocytosis
内皮 Weibel-Palade 体生物发生和胞吐作用的分子机制
- 批准号:
10796566 - 财政年份:2023
- 资助金额:
$ 16.94万 - 项目类别:
Regulation of the MAVS Signalosome by RNA and RNA-binding Proteins
RNA 和 RNA 结合蛋白对 MAVS 信号体的调节
- 批准号:
10640526 - 财政年份:2023
- 资助金额:
$ 16.94万 - 项目类别:
Identifying the mechanism of olfactory receptor gene regulation in olfactory neurons with live-cell imaging
通过活细胞成像识别嗅觉神经元中嗅觉受体基因调控的机制
- 批准号:
10722860 - 财政年份:2023
- 资助金额:
$ 16.94万 - 项目类别:
NOT-gated CAR T cells to overcome on-target, off-tumor toxicity in AML
非门控 CAR T 细胞可克服 AML 中的靶向、肿瘤外毒性
- 批准号:
10696150 - 财政年份:2022
- 资助金额:
$ 16.94万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 16.94万 - 项目类别: